SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-085617
Filing Date
2023-07-31
Accepted
2023-07-31 08:28:56
Documents
20
Period of Report
2023-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322386d1_8k.htm   iXBRL 8-K 35494
2 EXHIBIT 4.1 tm2322386d1_ex4-1.htm EX-4.1 107080
3 EXHIBIT 4.2 tm2322386d1_ex4-2.htm EX-4.2 107264
4 EXHIBIT 4.3 tm2322386d1_ex4-3.htm EX-4.3 105709
5 EXHIBIT 5.1 tm2322386d1_ex5-1.htm EX-5.1 16546
6 EXHIBIT 10.1 tm2322386d1_ex10-1.htm EX-10.1 220426
7 EXHIBIT 99.1 tm2322386d1_ex99-1.htm EX-99.1 14080
11 GRAPHIC image_001.jpg GRAPHIC 4235
12 GRAPHIC tm2322386d1_ex99-1img01.jpg GRAPHIC 7396
  Complete submission text file 0001104659-23-085617.txt   942597

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20230728.xsd EX-101.SCH 3027
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20230728_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20230728_pre.xml EX-101.PRE 22367
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2322386d1_8k_htm.xml XML 3414
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 231125153
SIC: 2834 Pharmaceutical Preparations